Genís Oña

721 total citations
40 papers, 451 citations indexed

About

Genís Oña is a scholar working on Clinical Psychology, Pharmacology and Nutrition and Dietetics. According to data from OpenAlex, Genís Oña has authored 40 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Clinical Psychology, 17 papers in Pharmacology and 13 papers in Nutrition and Dietetics. Recurrent topics in Genís Oña's work include Psychedelics and Drug Studies (32 papers), Cannabis and Cannabinoid Research (16 papers) and Biochemical Analysis and Sensing Techniques (13 papers). Genís Oña is often cited by papers focused on Psychedelics and Drug Studies (32 papers), Cannabis and Cannabinoid Research (16 papers) and Biochemical Analysis and Sensing Techniques (13 papers). Genís Oña collaborates with scholars based in Spain, Brazil and Denmark. Genís Oña's co-authors include José Carlos Bouso, Rafael G. dos Santos, Jaime E. C. Hallak, Miguel Ángel Alcázar‐Córcoles, Juliana Mendes Rocha, Giordano Novak Rossi, María Teresa Colomina, Dóra Révész, Maurı́cio Yonamine and Eduardo José Crevelin and has published in prestigious journals such as Scientific Reports, Neuroscience & Biobehavioral Reviews and Psychopharmacology.

In The Last Decade

Genís Oña

36 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Genís Oña Spain 13 378 148 142 118 102 40 451
Giordano Novak Rossi Brazil 13 363 1.0× 146 1.0× 147 1.0× 139 1.2× 161 1.6× 31 466
Elisabet Domínguez‐Clavé Spain 10 511 1.4× 174 1.2× 142 1.0× 172 1.5× 103 1.0× 17 552
Juliana Mendes Rocha Brazil 11 296 0.8× 129 0.9× 112 0.8× 113 1.0× 117 1.1× 19 355
Cory R. Weissman Canada 13 437 1.2× 260 1.8× 73 0.5× 153 1.3× 126 1.2× 32 643
Eduardo Ekman Schenberg Brazil 12 457 1.2× 218 1.5× 89 0.6× 252 2.1× 87 0.9× 21 564
Pablo Friedländer Spain 4 525 1.4× 211 1.4× 194 1.4× 241 2.0× 114 1.1× 5 558
Federico Zamberlán Argentina 12 344 0.9× 136 0.9× 78 0.5× 167 1.4× 53 0.5× 16 491
Pål-Ørjan Johansen Norway 4 472 1.2× 243 1.6× 87 0.6× 187 1.6× 57 0.6× 4 488
Erwin Krediet Netherlands 6 349 0.9× 196 1.3× 44 0.3× 145 1.2× 65 0.6× 7 413
Josep María Fábregas Spain 5 457 1.2× 157 1.1× 195 1.4× 217 1.8× 117 1.1× 7 505

Countries citing papers authored by Genís Oña

Since Specialization
Citations

This map shows the geographic impact of Genís Oña's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Genís Oña with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Genís Oña more than expected).

Fields of papers citing papers by Genís Oña

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Genís Oña. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Genís Oña. The network helps show where Genís Oña may publish in the future.

Co-authorship network of co-authors of Genís Oña

This figure shows the co-authorship network connecting the top 25 collaborators of Genís Oña. A scholar is included among the top collaborators of Genís Oña based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Genís Oña. Genís Oña is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Madero, Santiago, et al.. (2025). Current perspectives on psychedelic treatments in Europe. The Lancet Regional Health - Europe. 61. 101537–101537.
2.
Timmermann, Christopher, Genís Oña, Natasha L. Mason, et al.. (2025). Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness. Neuroscience of Consciousness. 2025(1). niaf007–niaf007. 3 indexed citations
3.
Oña, Genís, Elena Muñoz Marrón, Luís Heredia, et al.. (2024). Validation of the Spanish version of the multifaceted empathy test: comparison between cannabis use effects and controls in social cognition. International Clinical Psychopharmacology. 40(2). 100–109.
4.
Oña, Genís, et al.. (2024). A transcriptomic analysis in mice following a single dose of ibogaine identifies new potential therapeutic targets. Translational Psychiatry. 14(1). 41–41. 1 indexed citations
5.
Oña, Genís, et al.. (2023). Spanish versions and validation of a series of rating scales and visual analogue scales to assess the subjective effects of cannabis. International Clinical Psychopharmacology. 40(2). 91–99. 1 indexed citations
7.
Oña, Genís, et al.. (2023). Cannabis and Public Health: A Study Assessing Regular Cannabis Users Through Health Indicators. Cannabis and Cannabinoid Research. 9(2). 659–668. 4 indexed citations
8.
Rocha, Juliana Mendes, Giordano Novak Rossi, Genís Oña, et al.. (2023). Neural Network Modulation of Ayahuasca: A Systematic Review of Human Studies. MDPI (MDPI AG). 2(1). 76–91.
9.
Bouso, José Carlos, Dóra Révész, Genís Oña, et al.. (2023). Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic. Scientific Reports. 13(1). 14052–14052. 4 indexed citations
11.
Bouso, José Carlos, et al.. (2023). Hallucinations and Hallucinogens: Psychopathology or Wisdom?. Culture Medicine and Psychiatry. 47(2). 576–604. 4 indexed citations
12.
Bouso, José Carlos, et al.. (2023). Ayahuasca-induced personal death experiences: prevalence, characteristics, and impact on attitudes toward death, life, and the environment. Frontiers in Psychiatry. 14. 1287961–1287961. 4 indexed citations
13.
Oña, Genís, et al.. (2022). Underground ibogaine use for the treatment of substance use disorders: A qualitative analysis of subjective experiences. Drug and Alcohol Review. 42(2). 401–414. 8 indexed citations
14.
Oña, Genís, et al.. (2022). Jailhouse rock: Health status, patterns of use, and subjective benefits of cannabis use in a sample of inmates in Spanish prisons. Revista Española de Sanidad Penitenciaria. 24(1). 9–14. 2 indexed citations
15.
Oña, Genís, José Carlos Bouso, Airy Gras, et al.. (2021). The Use of Cannabis sativa L. for Pest Control: From the Ethnobotanical Knowledge to a Systematic Review of Experimental Studies. Cannabis and Cannabinoid Research. 7(4). 365–387. 7 indexed citations
16.
Oña, Genís, Juliana Mendes Rocha, José Carlos Bouso, et al.. (2021). The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020). Psychopharmacology. 239(6). 1977–1987. 24 indexed citations
17.
Révész, Dóra, Genís Oña, Giordano Novak Rossi, et al.. (2021). Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study. Frontiers in Psychiatry. 12. 687546–687546. 22 indexed citations
18.
Bouso, José Carlos, Genís Oña, Rafael G. dos Santos, & Jaime E. C. Hallak. (2021). Psychedelic Medicines in Major Depression: Progress and Future Challenges. Advances in experimental medicine and biology. 1305. 515–533. 6 indexed citations
19.
Oña, Genís & José Carlos Bouso. (2020). Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review. Neuroscience & Biobehavioral Reviews. 119. 194–203. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026